Clinical Trial Update: Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria [Phase 3]

View source ↗

Summary

Pfizer-conducted Phase 3 trial evaluating an antibiotic for catheter-related bloodstream infections caused by Gram-positive bacteria has completed, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Catheter-related Bloodstream Infection

Snippet

Sponsor: Pfizer | Conditions: Bacterial Infections, Gram-Positive Bacterial Infections | Phase 3 | Status: COMPLETED